European Journal of Hospital Pharmacy

Papers
(The H4-Index of European Journal of Hospital Pharmacy is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?45
Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatients39
Medication reconciliation—is it possible to speed up without compromising quality? A before–after study in the emergency department36
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?35
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document19
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews13
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series12
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing11
Spain takes over Presidency of the Council of the European Union10
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study10
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings10
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-1910
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide10
0.10690307617188